Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
1.130
-0.011 (-0.96%)
At close: Dec 19, 2025, 4:00 PM EST
1.130
0.00 (0.01%)
After-hours: Dec 19, 2025, 5:12 PM EST
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $9.2 million as of December 19, 2025. Its market cap has increased by 127.22% in one year.
Market Cap
9.20M
Enterprise Value
9.85M
1-Year Change
127.22%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $9.20M, a decrease of -97.79%. That is a compound annual growth rate of -41.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 9.20M | -41.40% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | 84.01M | -81.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |